Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Organigram Global Inc.NASDAQ: OGI

Weighted Avg Shares · Q2 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q2 FY2026 weighted avg shares of 131.57M shares rose 2.0% year over year, behind the +18.7% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 2.5% from the prior quarter.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.0% toward the trailing-twelve-month pace of +18.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
131.57M-2.5% QoQ
Last fiscal yearSep 2025
127.67M+34.0% YoY
LTMMar 2026
133.64M+18.7% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.0%——
1 year+34.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
127.67M CAD
Year-over-year change
+34.0%
4-year CAGR
+18.8%

Weighted Avg Shares vs competitors

How OGI compares with its peers on the latest reported figures

  • OGI's LTM Mar 2026 weighted avg shares of 133.64M shares is the 2nd highest of the 10 companies compared; the peer median is 26.2M shares.
  • Its year-over-year change of +18.7% is the 3rd highest of 9, against a peer median of +10.0%.
OGI Competitors Peer median
Weighted Avg Shares for OGI and competitors
Company Period LTM YoY 3-year CAGR
IVAInventiva S.A.FY2025186.8M +259.4%+65.2%
OGIOrganigram Global Inc.LTM Mar 2026133.64M +18.7%—
ACBAurora Cannabis Inc.LTM Mar 202655.98M +3.6%+20.7%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 202638.39M +2.6%+14.7%
LFCRLifecore Biomedical, Inc.LTM Mar 202637.34M —+5.7%
RNACCartesian Therapeutics, Inc.LTM Mar 202626.2M +16.5%+86.2%
HSDTSolana CompanyLTM Mar 202625.93M +788.1%+244.4%
DERMJourney Medical CorporationLTM Mar 202625.01M +17.3%+11.8%
INFUInfuSystem Holdings, Inc.LTM Mar 202620.52M -3.4%+0.0%
ELMDElectromed, Inc.LTM Mar 20268.28M -4.4%-0.5%
Peer median (excluding OGI) 26.2M+10.0%+14.7%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.